These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 33516459)
1. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer. Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459 [TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer. Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Aokage K; Saji H; Watanabe SI; J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1469-1480. PubMed ID: 32451073 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Very Small Ground-Glass Opacity Component in Stage IA Solid Predominant Non-small Cell Lung Cancer. Hattori A; Matsunaga T; Fukui M; Suzuki K; Takamochi K; Suzuki K Semin Thorac Cardiovasc Surg; 2024 Summer; 36(2):251-260. PubMed ID: 36180013 [TBL] [Abstract][Full Text] [Related]
4. Oncological characteristics of epidermal growth factor receptor-mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance. Hattori A; Matsunaga T; Fukui M; Tomita H; Takamochi K; Suzuki K J Thorac Cardiovasc Surg; 2024 Sep; 168(3):685-696.e2. PubMed ID: 37995863 [TBL] [Abstract][Full Text] [Related]
5. Minor (≤ 10%) Ground-Glass Opacity Component in Clinical Stage I Non-Small Cell Lung Cancer: Associations With Pathologic Characteristics and Clinical Outcomes. Li M; Wang J; Bao X; Wang F; Zhou F; Song N; Wan Z; Li W; Zhang L AJR Am J Roentgenol; 2024 Aug; 223(2):e2431283. PubMed ID: 38809121 [No Abstract] [Full Text] [Related]
6. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer. Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2102-2110.e1. PubMed ID: 28947198 [TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer. Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35293580 [TBL] [Abstract][Full Text] [Related]
8. Radiological classification of multiple lung cancers and the prognostic impact based on the presence of a ground glass opacity component on thin-section computed tomography. Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K Lung Cancer; 2017 Nov; 113():7-13. PubMed ID: 29110852 [TBL] [Abstract][Full Text] [Related]
9. Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer. Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K Ann Thorac Surg; 2016 Aug; 102(2):407-15. PubMed ID: 27177840 [TBL] [Abstract][Full Text] [Related]
10. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm. Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M Jpn J Clin Oncol; 2020 Oct; 50(11):1306-1312. PubMed ID: 32901276 [TBL] [Abstract][Full Text] [Related]
11. Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer. Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K Ann Thorac Surg; 2017 Jul; 104(1):313-320. PubMed ID: 28433219 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Classification of Multiple Primary Lung Cancers Based on a Ground-Glass Opacity Component. Hattori A; Takamochi K; Oh S; Suzuki K Ann Thorac Surg; 2020 Feb; 109(2):420-427. PubMed ID: 31593656 [TBL] [Abstract][Full Text] [Related]
13. Ten-Year Follow-Up of Lung Cancer Patients with Resected Stage IA Invasive Non-Small Cell Lung Cancer. Li X; Fan F; Yang Z; Huang Q; Fu F; Zhang Y; Chen H Ann Surg Oncol; 2024 Sep; 31(9):5729-5737. PubMed ID: 38888859 [TBL] [Abstract][Full Text] [Related]
14. Predicting recurrence of non-small cell lung cancer based on mean computed tomography value. Tamura M; Matsumoto I; Tanaka Y; Saito D; Yoshida S; Takata M J Cardiothorac Surg; 2021 May; 16(1):128. PubMed ID: 33980268 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer. Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958 [TBL] [Abstract][Full Text] [Related]
16. Extent of mediastinal nodal dissection in stage I non-small cell lung cancer with a radiological pure-solid appearance. Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K Eur J Surg Oncol; 2021 Jul; 47(7):1797-1804. PubMed ID: 33745792 [TBL] [Abstract][Full Text] [Related]
17. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy. Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781 [TBL] [Abstract][Full Text] [Related]
18. Postoperative Recurrence and Survival After Segmentectomy for Clinical Stage 0 or IA Lung Cancer. Kamigaichi A; Tsutani Y; Fujiwara M; Mimae T; Miyata Y; Okada M Clin Lung Cancer; 2019 Sep; 20(5):397-403.e1. PubMed ID: 31281050 [TBL] [Abstract][Full Text] [Related]
19. What is the radiological definition of part-solid tumour in lung cancer?†. Matsunaga T; Suzuki K; Takamochi K; Oh S Eur J Cardiothorac Surg; 2017 Feb; 51(2):242-247. PubMed ID: 28119328 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of CT-defined ground-glass opacity in early-stage lung adenocarcinomas: a single-center study and meta-analysis. Lee JH; Choi Y; Hong H; Kim YT; Goo JM; Kim H Eur Radiol; 2024 Mar; 34(3):1905-1920. PubMed ID: 37650971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]